IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis-Reference-Cited by-同舟云学术

IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis

Published:2019-01-24 Issue:6 Volume:79 Page:1138-1150
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Bishnupuri Kumar S.^ORCID,Alvarado David M.^ORCID,Khouri Alexander N.,Shabsovich Mark,Chen Baosheng,Dieckgraefe Brian K.,Ciorba Matthew A.

Funder

Crohn's and Colitis Foundation

NIH

Washington University Digestive Diseases Research Core Center

Siteman Cancer Center

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum targeted metabolomics uncovering specific amino acid signature for diagnosis of intrahepatic cholangiocarcinoma;Journal of Pharmaceutical and Biomedical Analysis;2025-01

2. IDO1 inhibitors are synergistic with CXCL10 agonists in inhibiting colon cancer growth;Biomedicine & Pharmacotherapy;2024-10

3. Loss of DOCK2 potentiates Inflammatory Bowel Disease–associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expression;Oncogene;2024-09-07

4. Proteomics Analysis of Renal Cell Line Caki-2 with AFMID Overexpression and Potential Biomarker Discovery in Urine;Journal of Proteome Research;2024-08-30

5. A Narrative Review: Immunometabolic Interactions of Host–Gut Microbiota and Botanical Active Ingredients in Gastrointestinal Cancers;International Journal of Molecular Sciences;2024-08-22